Radford joins Nanosonics
Thursday, 05 June, 2008
Nanosonics Ltd (ASX: NAN) has appointed a new CEO to lead the disinfection technology company's latest product roll-out.
The new CEO, David Radford, has 20 years of experience in the medical device and healthcare industries. He also has an honours degree in applied biological science from Bristol Polytechnic.
The company said Radford has extensive experience driving rapid growth in the ultrasound product market, which makes him the perfect person to oversee the company's roll-out of its new ultrasound disinfection devices.
Radford takes the helm from Nanosonics CFO Chris Grundy, who had been acting as CEO, and from Dr David Fisher, who had taken on the role of interim executive director.
Ultra-processed foods linked to poor health, premature death
Evidence suggests a dose-response relationship between ultra-processed food consumption and...
Shorter radiotherapy course proves safe for prostate cancer
A significantly shorter course of radiotherapy for localised prostate cancer is just as safe and...
5-in-1 meningococcal vaccine proves effective
A life-saving meningococcal vaccine covering all five common strains of the deadly disease could...
